Format

Send to

Choose Destination
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1023-30. doi: 10.1016/j.addr.2010.07.004. Epub 2010 Jul 21.

Multifunctional agents for concurrent imaging and therapy in cardiovascular disease.

Author information

1
Center for Systems Biology, Harvard Medical School, Massachusetts General Hospital, Charlestown, 02129, USA. jason_mccarthy@hms.harvard.edu

Abstract

The development of agents for the simultaneous detection and treatment of disease has recently gained significant attention. These multifunctional theranostic agents posses a number of advantages over their monofunctional counterparts, as they potentially allow for the concomitant determination of agent localization, release, and efficacy. Whereas the development of these agents for use in cancers has received the majority of the attention, their use in cardiovascular disease is steadily increasing. As such, this review summarized some of the most poignant recent advances in the development of theranostic agents for the treatment of this class of diseases.

PMID:
20654664
PMCID:
PMC2974776
DOI:
10.1016/j.addr.2010.07.004
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center